Home/Filings/4/0001104659-24-060889
4//SEC Filing

Lebovits Chaim 4

Accession 0001104659-24-060889

CIK 0001137883other

Filed

May 13, 8:00 PM ET

Accepted

May 14, 7:53 AM ET

Size

8.9 KB

Accession

0001104659-24-060889

Insider Transaction Report

Form 4
Period: 2024-05-10
Lebovits Chaim
President & CEO
Transactions
  • Award

    Common Stock

    2024-05-13$0.49/sh+10,000$4,9001,099,865 total
  • Award

    Common Stock

    2024-05-11$0.47/sh+10,000$4,6651,089,865 total
  • Award

    Common Stock

    2024-05-10$0.47/sh+20,000$9,3001,079,865 total
Holdings
  • Common Stock

    (indirect: See footnote)
    2,000,847
Footnotes (1)
  • [F1]Includes (i) 1,933,794 shares of Common Stock owned by ACCBT Corp. and (ii) 67,053 shares of Common Stock owned by ACC International Holdings Ltd. Reporting Person may be deemed the beneficial owner of these shares.

Issuer

BRAINSTORM CELL THERAPEUTICS INC.

CIK 0001137883

Entity typeother

Related Parties

1
  • filerCIK 0001406302

Filing Metadata

Form type
4
Filed
May 13, 8:00 PM ET
Accepted
May 14, 7:53 AM ET
Size
8.9 KB